Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Actuate Therapeutics Inc.
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
AIDS Malignancy Consortium
University of California, San Francisco
National Cancer Institute (NCI)